Sulfite tolerance in recombinant yeast host cells

US12442009B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12442009-B2
Application numberUS-201716472742-A
CountryUS
Kind codeB2
Filing dateDec 22, 2017
Priority dateDec 22, 2016
Publication dateOct 14, 2025
Grant dateOct 14, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure concerns the use of specific genetic modification(s) for improving sulfite tolerance in recombinant yeast host cells. The genetic modification(s) is (are) designed to allow the expression of an heterologous transcription factor favoring the expression of a SSU1 polypeptide and/or the expression of an heterologous SSU1 polypeptide in the recombinant yeast host cell(s).

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant yeast host cell comprising: (i) at least one first genetic modification selected from the group consisting of: a heterologous nucleic acid molecule encoding a heterologous STL1 polypeptide, and a heterologous nucleic acid molecule encoding a heterologous glucoamylase, wherein the heterologous glucoamylase comprises: (i) the amino acid sequence of any one of SEQ ID NO: 13, 14, 15, 16, 17, 18, and 19, (ii) a variant having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 13, 14, 15, 16, 17, 18, and 19, or (iii) a fragment of (i) or (ii) having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 13, 14, 15, 16, 17, 18, and 19, wherein the variant or the fragment has glucoamylase activity; and (ii) at least one second genetic modification selected from the group consisting of: a heterologous nucleic acid molecule encoding a heterologous transcription factor FZF1 polypeptide, wherein the heterologous transcription factor FZF1 polypeptide comprises: (i) the amino acid sequence of any one of SEQ ID NO: 1 to 6, 21 and 22, (ii) a variant having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 1 to 6, 21 and 22, or (iii) a fragment of (i) or (ii) having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 1 to 6, 21 and 22, wherein the variant or the fragment of the heterologous transcription factor FZF1 polypeptide favors the expression of a native SSU1 polypeptide, the heterologous SSU1 polypeptide, or both the native SSU1 polypeptide and the heterologous SSU1 polypeptide; and a heterologous nucleic acid molecule encoding a heterologous SSU1 polypeptide, wherein the heterologous SSU1 polypeptide comprises: (i) the amino acid sequence of any one of SEQ ID NO: 7 to 12, 23, 24, and 25, (ii) a variant having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 7 to 12, 23, 24, and 25, or (iii) a fragment of (i) or (ii) having at least 70% identity with the amino acid sequence of any one of SEQ ID NO: 7 to 12, 23, and 24, wherein the variant or the fragment has sulfite efflux activity. 2. The recombinant yeast host cell of claim 1 having the heterologous nucleic acid molecule encoding the heterologous transcription factor FZF1 polypeptide. 3. The recombinant yeast host cell of claim 2 , wherein the heterologous transcription factor FZF1 polypeptide is expressed under the control of a constitutive, a glucose-regulated or a sulfite-regulated promoter. 4. The recombinant yeast host cell of claim 3 , wherein the promoter is (i) the glucose-regulated promoter, wherein the glucose-regulated promoter is the promoter of a hxt7 gene (hxt7p) or (ii) the sulfite-regulated promoter, wherein the sulfite-regulated promoter is the promoter of a gpd2 gene (gpd2p), the promoter of a fzf1 gene (fzf1p), the promoter of a ssu1 gene (ssu1p) or the promoter of a ssu1-r gene (ssur1-rp). 5. The recombinant yeast host cell of claim 2 , wherein the heterologous transcription factor FZF1 polypeptide is from a species of genus Saccharomyces. 6. The recombinant yeast host cell of claim 1 having the heterologous nucleic acid molecule encoding the heterologous SSU1 polypeptide. 7. The recombinant yeast host cell of claim 6 , wherein the heterologous SSU1 polypeptide is (i) a polypeptide encoded by a ssu1 gene ortholog, and/or (ii) expressed under control of a constitutive, a glucose-regulated or a sulfite-regulated promoter. 8. The recombinant yeast host cell of claim 6 , wherein the heterologous SSU1 polypeptide is from a species of genus Saccharomyces. 9. The recombinant yeast host cell of claim 1 , having the heterologous nucleic acid molecule encoding the heterologous STL1 polypeptide. 10. The recombinant yeast host cell of claim 1 having the heterologous nucleic acid molecule encoding the heterologous glucoamylase. 11. The recombinant yeast host cell of claim 1 , further comprising a third genetic modification for reducing the production of the one or more native enzymes that function to catabolize formate. 12. The recombinant yeast host cell of claim 1 being from a species of genus Saccharomyces. 13. The recombinant yeast host cell of claim 12 being from the species Saccharomyces cerevisiae. 14. A method of improving a growth property of a recombinant yeast host cell, said method comprising: (i) providing a first recombinant yeast host cell having the first genetic modification defined in claim 1 ; and (ii) introducing the second genetic modification defined in claim 1 in the first recombinant yeast host cell to provide a second recombinant yeast host cell, wherein the growth property of the second recombinant yeast host cell is improved with respect to the growth property of the first recombinant yeast host cell.

Assignees

Inventors

Classifications

  • Saccharomyces cerevisiae · CPC title

  • Saccharomyces isolates · CPC title

  • Biofuels, e.g. bio-diesel · CPC title

  • Ethanol, i.e. non-beverage · CPC title

  • DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12442009B2 cover?
The present disclosure concerns the use of specific genetic modification(s) for improving sulfite tolerance in recombinant yeast host cells. The genetic modification(s) is (are) designed to allow the expression of an heterologous transcription factor favoring the expression of a SSU1 polypeptide and/or the expression of an heterologous SSU1 polypeptide in the recombinant yeast host cell(s).
Who is the assignee on this patent?
Lallemand Hungary Liquidity Man Llc, Danstar Ferment Ag
What technology area does this patent fall under?
Primary CPC classification C12N15/81. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).